Aarey Drugs & Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹66.60(0.83%)July 18, 2025 15:15:00 PM IST
- NSE
- BSE
- Vol : 39.63K (NSE + BSE)Last 20 day avg : 100.16 K
Aarey Drugs & Pharmaceuticals is trading 0.83% upper at Rs 66.60 as compared to its last closing price. Aarey Drugs & Pharmaceuticals has been trading in the price range of 67.37 & 64.73. Aarey Drugs & Pharmaceuticals has given 14.66% in this year & -8.55% in the last 5 days. Aarey Drugs & Pharmaceuticals has TTM P/E ratio 25.98 as compared to the sector P/E of 25.87.The company posted a net profit of 0.47 Crores in its last quarter.Listed peers of Aarey Drugs & Pharmaceuticals include Bafna Pharmaceuticals (-1.18%), Coral Laboratories (-1.41%), Aarey Drugs & Pharmaceuticals (0.83%).The Mutual Fund holding in Aarey Drugs & Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Aarey Drugs & Pharmaceuticals was at 2.34% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jul 19, 2025, 10:46 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values1.47The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values56.14Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility1.71Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.25The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable
The company's revenue fell during March quarter by 48.61% from Rs 210.35 crore to Rs 108.10 crore, year-on-year- The company's profit declined by 78.15% year-on-year during the March quarter, dropping from Rs 2.15 crore to Rs 0.47 crore
- The debt to equity of the company is higher than the industry median
- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 71.52
- R2
- 75.45
- R3
- 78.16
- S1
- 64.88
- S2
- 62.17
- S3
- 58.24
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Bafna Pharmaceuticals | Bullish | 89.00 | -1.18 | 210.19 | 51.17 | 2.51 | - | 16.54 |
| Coral Laboratories | Bearish | 592.45 | -1.41 | 211.66 | 8.49 | 1.04 | 0.34 | - |
| Aarey Drugs & Pharmaceuticals | Neutral | 66.60 | 0.83 | 188.84 | 38.59 | 1.44 | - | 1.43 |
| Chemcrux Enterprises | Bearish | 129.90 | 0.35 | 191.85 | 49.91 | 2.61 | 0.76 | 38.40 |
| Murae Organisor | Neutral | 0.93 | - | 172.88 | 25.50 | 0.91 | - | 102.06 |
- Promoter(s) holding is moderate at 44.80%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding is constant over the last quarter at 2.34%
- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-12-04 | To consider Fund Raising |
| 2024-11-29 | Preferential issue of shares |
| 2024-11-14 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE198H01019
- BSE Code524412
- NSE CodeAAREYDRUGS
Aarey Drugs & Pharmaceuticals is trading at 66.60 as on Fri Jul 18 2025 09:45:00. This is 0.83% upper as compared to its previous closing price of 66.05.
The market capitalization of Aarey Drugs & Pharmaceuticals is 188.84 Cr as on Fri Jul 18 2025 09:45:00.
The 52 wk high for Aarey Drugs & Pharmaceuticals is 75.75 whereas the 52 wk low is 31.30
Aarey Drugs & Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 25.98
- Sector P/E: 25.87
- Dividend Yield: 0.00%
- D/E ratio: 0.25
Aarey Drugs & Pharmaceuticals reported a net profit of 4.02 Cr in 2025.